These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2556725)

  • 1. Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans.
    Born J; Kern W; Pietrowsky R; Sittig W; Fehm HL
    Psychopharmacology (Berl); 1989; 99(4):439-44. PubMed ID: 2556725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10.
    Born J; Bräuninger W; Fehm-Wolfsdorf G; Voigt KH; Pauschinger P; Fehm HL
    Exp Brain Res; 1987; 67(1):85-92. PubMed ID: 3040455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of ACTH 4-10 effects on human attention.
    Born J; Unseld U; Pietrowsky R; Bickel U; Voigt K; Fehm HL
    Neuroendocrinology; 1990 Aug; 52(2):169-74. PubMed ID: 2177158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of ACTH 4-10 on event-related potentials reflecting attention in man.
    Born J; Fehm-Wolfsdorf G; Voigt KH; Fehm HL
    Physiol Behav; 1987; 39(1):83-7. PubMed ID: 3031714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R; Perras B; Molle M; Fehm HL; Born J
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R; Mölle M; Fehm HL; Born J
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ACTH 4-9 analog impairs selective attention in man.
    Born J; Fehm-Wolfsdorf G; Schiebe M; Birbaumer N; Fehm HL; Voigt KH
    Life Sci; 1985 Jun; 36(22):2117-25. PubMed ID: 2987636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain evoked responses, a bioassay for central actions of adrenocorticotropin (ACTH 1-39) and corticotropin releasing hormone (CRH) in humans.
    Born J; Seidel E; Pietrowsky R; Fehm HL
    Horm Metab Res; 1991 Mar; 23(3):126-30. PubMed ID: 1650750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropin widens the focus of attention in humans. A nonliner electroencephalographic analysis.
    Mölle M; Albrecht C; Marshall L; Fehm HL; Born J
    Psychosom Med; 1997; 59(5):497-502. PubMed ID: 9316182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an ACTH/MSH(4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans.
    Steiger A; Guldner J; Knisatschek H; Rothe B; Lauer C; Holsboer F
    Peptides; 1991; 12(5):1007-10. PubMed ID: 1666179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticotropin releasing hormone on human brain function: an analysis based on auditory evoked potentials.
    Fehm HL; Born J
    Horm Metab Res Suppl; 1987; 16():75-9. PubMed ID: 2832298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an ACTH 4-9 analog on auditory evoked brainstem responses and middle latency responses.
    Born J; Fehm-Wolfsdorf G; Nagel DJ; Voigt KH; Fehm HL
    Pharmacol Biochem Behav; 1985 Sep; 23(3):367-72. PubMed ID: 2996028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distractability under the influence of an ACTH 4-9 derivative.
    Rockstroh B; Elbert T; Lutzenberger W; Birbaumer N; Voigt KH; Fehm HL
    Int J Neurosci; 1983 Dec; 22(1-2):21-36. PubMed ID: 6321376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons.
    Schreiber H; Stolz-Born G; Pietrowsky R; Kornhuber HH; Fehm HL; Born J
    Biol Psychiatry; 1995 May; 37(10):702-12. PubMed ID: 7640325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH and attention in humans: a review.
    Born J; Fehm HL; Voigt KH
    Neuropsychobiology; 1986; 15(3-4):165-86. PubMed ID: 3024062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dishabituating effects of an ACTH 4-9 analog in a vigilance task.
    Born J; Fehm-Wolfsdorf G; Schiebe M; Rockstroh B; Fehm HL; Voigt KH
    Pharmacol Biochem Behav; 1984 Oct; 21(4):513-9. PubMed ID: 6095322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of ACTH fragments on hippocampal EEG and behavior.
    Fontani G; Grazzi F; Aloisi AM
    Neuropsychobiology; 1987; 17(3):169-72. PubMed ID: 2825068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP).
    Born J; Bathelt B; Pietrowsky R; Pauschinger P; Fehm HL
    Psychopharmacology (Berl); 1990; 101(1):34-8. PubMed ID: 2160665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH 4-9 effects on the human visual event-related potential.
    Sandman CA; Berka C; Walker BB; Veith J
    Peptides; 1985; 6(5):803-7. PubMed ID: 3001664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of a vasopressin-analogue (DGAVP) on event-related potentials in a stimulus-mismatch paradigm.
    Pietrowsky R; Born J; Fehm-Wolfsdorf G; Fehm HL
    Biol Psychol; 1989 Jun; 28(3):239-50. PubMed ID: 2686760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.